Ce înseamnă „Clear”?
Animalul nu poartă mutația. Nu va dezvolta boala și nu o va transmite mai departe.
Câine Sindromul miastenic congenital la Heideterrier (CMS-H)
Discover the importance of the DNA test for Congenital Myasthenic Syndrome (CMS) in Heideterriers, a hereditary neuromuscular disorder affecting this unique dog breed. Early genetic screening helps breeders identify carriers and prevent the transmission of CMS, ensuring healthier litters. This precise DNA test detects mutations linked to CMS, allowing for informed breeding decisions and improved canine health. Regular testing supports responsible breeding practices and enhances the overall well-being of Heideterriers. Protect your dog’s future by choosing reliable CMS DNA testing today. Stay proactive in managing congenital health risks with advanced genetic tools.
Abreviere: CMS-H
Mutația analizată: CHRNE c.1436_1437insG
Moștenire: Autosomal recesiv
Acronim
CMS-H
Frecvența observată
Severitate clinică
Clasificare clinică
Boli neuromusculare
Mutație analizată
CHRNE c.1436_1437insG
p.(S503Rfs*14)
p.(S503Rfs*14)
Modul de moștenire
Autosomal recesiv
Rezumatul testului:
The DNA test for Congenital Myasthenic Syndrome (CMS) in Heideterriers helps identify genetic mutations responsible for this inherited neuromuscular disorder. CMS causes muscle weakness and fatigue due to impaired nerve-to-muscle communication. Early detection through genetic testing enables breeders to make informed decisions and reduce the risk of passing the condition to offspring. This test is essential for maintaining the health and vitality of the Heideterrier breed. Regular screening supports responsible breeding and improves overall canine welfare.
Disponibil din pachet: Basic
Acest test ADN este inclus începând din pachetul nostru Basic — și face parte și din pachete Basic, Standard, Advanced, Complete.
Vizualizați pachetele de teste ADN →Alege haita care se potrivește cel mai bine cu strategia ta de creștere sau de sănătate a animalelor tale.
Overview of Congenital Myasthenic Syndrome (CMS)
Congenital Myasthenic Syndrome (CMS) is a group of inherited neuromuscular disorders characterized by weakness and fatigue of voluntary muscles. This condition results from defects in the transmission of nerve impulses to muscles, leading to compromised muscle function. It is caused by genetic mutations that affect the proteins responsible for neuromuscular transmission, notably at the neuromuscular junction where nerve cells communicate with muscles.
Symptoms of CMS in Dogs
Dogs affected by CMS may exhibit a range of symptoms, including muscle weakness, exercise intolerance, and fatigue. Some dogs may also show signs of difficulty in swallowing, facial muscle weakness, and a tendency to collapse after exertion. These symptoms can vary in severity and may be mistaken for other conditions, making a proper diagnosis crucial for effective management.
Importance of DNA Testing for CMS
DNA testing plays a vital role in identifying genetic mutations associated with Congenital Myasthenic Syndrome. By analyzing specific genes known to be linked to CMS, veterinarians and breeders can better understand the genetic predisposition of individual dogs. This information is crucial for making informed breeding decisions and helps in managing the condition in affected dogs.
Opțiuni de management și tratament
Currently, there is no cure for Congenital Myasthenic Syndrome; however, management strategies are available to improve the quality of life for affected dogs. Treatment often includes the use of medications such as anticholinesterase agents, which can enhance neuromuscular transmission. Supportive care, including physical therapy and nutritional management, is also essential to help maintain muscle function and overall health.
Concluzie
Congenital Myasthenic Syndrome is a serious condition that can significantly affect the life of a dog. Early diagnosis through DNA testing can facilitate proper management and care, ensuring that affected dogs receive the support they need to lead a fulfilling life. Understanding the implications of this condition is vital for dog owners, breeders, and veterinary professionals alike.
Rasa recunoscută pentru test: Sindromul miastenic congenital la Heideterrier (CMS-H)
- Heideterrier
- Smooth Fox Terrier
🧬 Interpretation of genotypes CMS-H
Genotip
Stare
🟡 N/N
Non-transportator - Fără risc
🟡 N/CMS-H
Transportator - Fără risc
❌ CMS-H/CMS-H
Afectat - În pericol
Întrebări frecvente: înțelegerea interpretării
Un „Carrier” este serios?
Nu. Animalul este în general sănătos, dar poate transmite mutația acestuia urmas.
Ce se întâmplă dacă un animal este „Afectat”?
Are două copii mutante. Se așteaptă semne clinice în funcție de boala. Nu trebuie crescut.
De ce există diferențe între bărbat/femeie?
Unele boli sunt legate de sex, astfel încât expresia lor variază în funcție de sexul animalului.
Prezice descendenții
N/N (netransportator)
N/CMS-H (Purtător)
CMS-H/CMS-H (Afectat)
Întrebări frecvente despre testul ADN
Ce detectează acest test ADN?
This DNA test detects the mutation associated with Congenital Myasthenic Syndrome In Heideterrier (CMS-H) in order to identify clear, carrier, or at-risk animals.
De ce testați un animal de reproducție?
Testarea ADN îi ajută pe crescători să planifice împerecheri mai sigure și să reducă riscul de transmitere a mutației către descendenți.
Care este modul de moștenire al acestui test?
Modul de moștenire raportat pentru acest test este autosomal recesiv.
Ce mutație este analizată în acest test?
This test analyses the mutation CHRNE c.1436_1437insG.
Este neapărat afectat un animal purtător?
Nu neapărat. Interpretarea depinde de modelul de moștenire și de genotipul rezultat.
Referințe
Herder Vanessa, Ciurkiewicz Malgorzata, Baumgärtner Wolfgang, Jagannathan Vidhya, Leeb Tosso. Frame-shift variant in the CHRNE gene in a juvenile dog with suspected myasthenia gravis-like disease. Anim Genet. 2017 Oct;48(5):625. doi: 10.1111/age.12558. Epub 2017 May 16.